Boston Scientific Corp.’s recently made public that its Director LUDWIG EDWARD J unloaded Company’s shares for reported $0.72 million on Apr 26 ’24. In the deal valued at $73.29 per share,9,818 shares were sold. As a result of this transaction, LUDWIG EDWARD J now holds 41,374 shares worth roughly $3.0 million.
Then, Sorenson John Bradley sold 16,351 shares, generating $1,133,069 in total proceeds. Upon selling the shares at $69.30, the EVP, Global Operations now owns 50,638 shares.
Before that, Carruthers Wendy sold 6,983 shares. Boston Scientific Corp. shares valued at $477,777 were divested by the EVP, Human Resources at a price of $68.42 per share. As a result of the transaction, Carruthers Wendy now holds 51,068 shares, worth roughly $3.7 million.
Mizuho upgraded its Boston Scientific Corp. [BSX] rating to a Buy from a a Neutral in a research note published on February 01, 2024; the price target was increased to $80 from $65. A number of analysts have revised their coverage, including Robert W. Baird’s analysts, who began to cover the stock in mid July with a ‘”an Outperform”‘ rating. CL King began covering BSX with “Buy” recommendation on June 30, 2023.
Price Performance Review of BSX
On Monday, Boston Scientific Corp. [NYSE:BSX] saw its stock fall -0.92% to $72.50. Over the last five days, the stock has gained 6.59%. Boston Scientific Corp. shares have risen nearly 25.41% since the year began. Nevertheless, the stocks have risen 39.34% over the past one year. While a 52-week high of $74.39 was reached on 04/24/24, a 52-week low of $48.35 was recorded on 01/02/24. SMA at 50 days reached $67.90, while 200 days put it at $58.08. A total of 9.46 million shares were traded, compared to the trading of 8.79 million shares in the previous session.
Levels Of Support And Resistance For BSX Stock
The 24-hour chart illustrates a support level at 71.79, which if violated will result in even more drops to 71.08. On the upside, there is a resistance level at 73.17. A further resistance level may holdings at 73.83. The Relative Strength Index (RSI) on the 14-day chart is 69.65, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 3.50, which suggests price will go up in the next trading period. Percent R suggests that price movement has been bullish at 24.90%. Stochastics %K at 81.38% indicates the stock is a selling.
The most recent change occurred on March 29, 2023 when UBS began covering the stock and recommended ‘”a Buy”‘ rating along with a $57 price target.
